In this video we look at the second half of 2026, focusing on why U.S. knee replacement growth may rebound despite a slower-than-expected start, the growing adoption of smaller-footprint orthopedic technologies and navigation systems as well as our outlook for the trauma market.
Mike Evers is an analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage. You can reach him by email.
In this video we look at the second half of 2026, focusing on why U.S. knee replacement growth may rebound despite a slower-than-expected start, the growing adoption of smaller-footprint orthopedic technologies and navigation systems as well as our outlook for the trauma market. Mike Evers is an analyst...
In this video we look at the second half of 2026, focusing on why U.S. knee replacement growth may rebound despite a slower-than-expected start, the growing adoption of smaller-footprint orthopedic technologies and navigation systems as well as our outlook for the trauma market.
Mike Evers is an analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage. You can reach him by email.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.